Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: Dosimetry/ISRTRD Alpha Symposium

Preclinical safety, biodistribution and dosimetry estimates of 99mTc-DTPA-glipizide as a novel compound imaging pancreatic islet cells

Ho-Chun Song, Saady Kohanim, Changsok Oh, Dong-Fang Yu, Richard Mendez, E. Edmund Kim and David J. Yang
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1844;
Ho-Chun Song
1The University of Texas M. D. Anderson Cancer Center, Division of Diagnostic Imaging, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saady Kohanim
1The University of Texas M. D. Anderson Cancer Center, Division of Diagnostic Imaging, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Changsok Oh
1The University of Texas M. D. Anderson Cancer Center, Division of Diagnostic Imaging, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dong-Fang Yu
1The University of Texas M. D. Anderson Cancer Center, Division of Diagnostic Imaging, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Mendez
1The University of Texas M. D. Anderson Cancer Center, Division of Diagnostic Imaging, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Edmund Kim
1The University of Texas M. D. Anderson Cancer Center, Division of Diagnostic Imaging, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Yang
1The University of Texas M. D. Anderson Cancer Center, Division of Diagnostic Imaging, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1844

Objectives This study aimed to evaluate the biodistribution, radiation dosimetry, and acute toxicity of 99mTc-DTPA-glipizide (DTPA-GLP) in rats.

Methods DTPA dianhydride conjugated with GLP in dimethylsulfoxide, yielded 60%. Biodistribution and planar images were obtained at 30-120 min after injection of 99mTc-DTPA-GLP (1 mg/rat) in healthy female Fischer 344 rats. Acute toxicity was studied with Fischer 344 male and female rats injected intravenously with 99mTc-DTPA-GLP (3, 10 mg/rat, 11.1 MBq/rat). Toxicity was evaluated by determination of biochemistry parameters. Radiation dosimetry projections in humans were estimated on the basis of the residence times in rats by use of the MIRDose 3.1 software package.

Results Structure of DTPA-GLP was confirmed by NMR, mass spectrometry and HPLC. Radiochemical purity assessed by ITLC was > 96%. 99mTc-DTPA-GLP showed increased pancreas-to-muscle ratios whereas 99mTc-DTPA showed decreased ratios at various time-points. Pancreas could be visualized with 99mTc-DTPA-GLP in normal rat, whereas no uptake in the pancreas was observed in rats pretreated with streptozotocin. Biochemistry results (ALT and AST, bilirubin, BUN, creatinine, and glucose levels) remained within or close to the normal ranges. The projected effective dose equivalent in humans was 0.0113 rem/mCi. Thehighest absorbed doses would be received by the kidney (0.0669 rem/mCi).

Conclusions 99mTc-DTPA-GLP is safe and feasible to assess pancreas beta cell receptor recognition.

  • © 2009 by Society of Nuclear Medicine
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preclinical safety, biodistribution and dosimetry estimates of 99mTc-DTPA-glipizide as a novel compound imaging pancreatic islet cells
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preclinical safety, biodistribution and dosimetry estimates of 99mTc-DTPA-glipizide as a novel compound imaging pancreatic islet cells
Ho-Chun Song, Saady Kohanim, Changsok Oh, Dong-Fang Yu, Richard Mendez, E. Edmund Kim, David J. Yang
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1844;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preclinical safety, biodistribution and dosimetry estimates of 99mTc-DTPA-glipizide as a novel compound imaging pancreatic islet cells
Ho-Chun Song, Saady Kohanim, Changsok Oh, Dong-Fang Yu, Richard Mendez, E. Edmund Kim, David J. Yang
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1844;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: Dosimetry/ISRTRD Alpha Symposium

  • Matched pair imaging for peptide targeted melanoma alpha-particle therapy
  • Probing the mechanism of Iodine-125 induced DNA damage
  • Calculation of cells underdose and overdose for tumor which received prescribed average absorbed dose
Show more Radiopharmaceutical Chemistry: Dosimetry/ISRTRD Alpha Symposium

Dosimetry/ISRTRD Posters

  • Matched pair imaging for peptide targeted melanoma alpha-particle therapy
  • Probing the mechanism of Iodine-125 induced DNA damage
  • Calculation of cells underdose and overdose for tumor which received prescribed average absorbed dose
Show more Dosimetry/ISRTRD Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire